Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Arch Virol. 1987; 96(1): 29–38.
PMCID: PMC7087211
PMID: 3619653

Antigenic and biological diversity of feline coronaviruses: feline infectious peritonitis and feline enteritis virus

Summary

Antigenically related feline coronaviruses cause two distinct disease manifestations in infected cats. The diseases are feline infectious peritonitis (FIP), in which the virus is widely disseminated, and feline enteric coronavirus (FECV), a mild disease in which the virus is usually limited to the villi. These two viruses were found to differ in their growth in cell culture. FIPV grows to higher titer, forms larger plaques and switches off host cell protein synthesis more effectively than FECV. Cross neutralization studies showed antigenic differences between the strains. There also appeared to be a difference in the nucleoprotein molecular weight of the viruses causing these two different disease syndromes.

Keywords: Peritonitis, Cell Protein, Mild Disease, Disease Manifestation, Distinct Disease

Footnotes

This work was supported by grant NIH/RR 01203-07.

References

1. Boyle JF, Pedersen NC, Evermann JF, McKeirnan AJ, Ott RL, Black JW. Plaque assay, polypeptide composition, and immunochemistry of feline infectious peritonitis virus and feline enteric coronavirus isolates. Adv Exp Med Biol. 1984;173:133–147. [PubMed] [Google Scholar]
2. Cheley S, Morris VL, Cupples MJ, Anderson R. RNA and polypeptide homology among murine coronavirus. Virology. 1981;115:310–321. [PMC free article] [PubMed] [Google Scholar]
3. Evermann JF, Baumgartener L, Ott RL, Davis EV, McKeirnan AJ. Characterization of a feline infectious peritonitis virus isolate. Vet Pathol. 1981;18:256–265. [PubMed] [Google Scholar]
4. Flintoff WF. Replication of murine coronaviruses in somatic cell hybrids formed between a mouse fibroblast cell line and either a rat schwannoma line or a rat glioma line. Adv Exp Med Biol. 1984;173:301–313. [PubMed] [Google Scholar]
5. Garwes DJ, Bountiff L, Millson GC, Elleman CJ. Defective replication of porcine transmissible gastroenteritis virus in a continuous cell line. Adv Exp Med Biol. 1984;173:79–93. [PubMed] [Google Scholar]
6. Garwes DJ, Pocock DH, Pike BV. Isolation of subviral components from transmissible gastroenteritis virus. J Gen Virol. 1976;32:283–294. [PubMed] [Google Scholar]
7. Horzinek MC, Osterhaus ADME. The virology and pathogenesis of feline infectious peritonitis. Arch Virol. 1979;59:1–15. [PMC free article] [PubMed] [Google Scholar]
8. Kenny GE. Immunogenicity of mycoplasma pneumoniae. Infect Immun. 1971;3:510–515. [PMC free article] [PubMed] [Google Scholar]
9. Kenny GE. Contamination of mammalian cells in culture with mycoplasmata. In: Fogh J, editor. Contamination in tissue culture. New York: Academic Press; 1973. pp. 107–129. [Google Scholar]
10. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. [PubMed] [Google Scholar]
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
12. McKeirnan AJ, Evermann JF, Hargis A, Miller LM, Ott RL. Isolation of feline coronavirus from two cats with diverse disease manifestations. Feline Pract. 1981;11:16–20. [Google Scholar]
13. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver strain for detecting proteins in polyacrylamide gels. Anal Biochem. 1980;105:361–363. [PubMed] [Google Scholar]
14. Pedersen NC. Feline infectious peritonitis and feline enteric coronavirus infection II. Feline infectious peritonitis. Feline Pract. 1983;13:5–20. [Google Scholar]
15. Pedersen NC, Black JW, Boyle JF, Evermann JF, McKeirnan AJ, Ott RL. Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol. 1984;173:365–380. [PubMed] [Google Scholar]
16. Pedersen NC, Boyle JF, Floyd K. An enteric coronavirus infection and its relationship to feline infectious peritonitis. Am J Vet Res. 1981;42:368–377. [PubMed] [Google Scholar]
17. Pedersen NC, Evermann JF, McKeirnan AJ, Ott L. Pathogenicity studies of feline coronavirus isolates 79–1146 and 79–1683. Am J Vet Res. 1984;45:2580–2585. [PubMed] [Google Scholar]
18. Reed LJ, Muench H. A simple method for estimating fifty percent endpoints. Am J Hyg. 1938;27:493–497. [Google Scholar]
19. Rottier PJM, Horzinek MC, van der Zeijst BAM. Viral protein synthesis in mouse hepatitis virus strain A 59-infected cells: effect of tunicamycin. J Virol. 1981;40:350–357. [PMC free article] [PubMed] [Google Scholar]
20. Sever JL. Application of a microtechnique to viral serological investigation. J Immunol. 1962;88:320–329. [PubMed] [Google Scholar]
21. Schmidt OW, Cooney MK, Kenny GE. Plaque assay and improved yield of human coronaviruses in a human rhabdomyosarcoma cell line. J Clin Micr. 1979;9:722–728. [PMC free article] [PubMed] [Google Scholar]
22. Schmidt OW, Kenny GE. Immunogenicity and antigenicity of human coronaviruses 229 E and OC 43. Infect Immun. 1981;32:1000–1006. [PMC free article] [PubMed] [Google Scholar]
23. Siddell SG, Wege H, Barthel A, ter Meulen V. Coronavirus JHM: intracellular protein synthesis. J Gen Virol. 1981;53:145–155. [PubMed] [Google Scholar]
24. Siddell St, Wege H, ter Meulen V. The structure and replication of coronaviruses. Curr Top Microbiol Immunol. 1982;99:131–163. [PubMed] [Google Scholar]
25. Sturman LS, Holmes KV. The molecular biology of coronaviruses. Adv Virus Res. 1983;28:35–112. [PMC free article] [PubMed] [Google Scholar]
26. Thouless ME. Rotavirus polypeptides. J Gen Virol. 1979;44:187–197. [PubMed] [Google Scholar]
27. Wege H, Siddell St, ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

-